It helps to reduce the tremor response in Parkinson's disease patients, reduces or eliminates tissue damage in diabetic patients, improves insulin resistance, reduces respiratory problems, reduces plaque build-up, and increases blood circulation in the arteries, among other effects
This means even individuals who have not lost significant weight may show improved lipid panels, a pattern that could suggest pharmacological intervention to an observant clinician
PlexusDx prices the Microdose GLP-1 Protocol at $129/mo flat, Semaglutide Injection at $189/mo, and Tirzepatide Injection at $289/mo cheaper at the entry tiers and competitive at the higher dose tiers
GLP-1 user base growing from approximately 10 million today to between 25 and 30 million by 2030 a 2.5x to 3x increase
It requires treating these research compounds with the respect their potential deserves